No image

cobas&#x00AE EZH2 Mutation Test

7258321190 · Roche Molecular Systems, Inc.

Details

Device typeEnhancer of zeste homolog 2 (EZH2) gene mutation IVD, kit, nucleic acid technique (NAT): A collection of reagents and other associated materials intended to be used to diagnose, monitor or predict the enhancer of zeste homolog 2 (EZH2) gene mutation status of a tumour tissue specimen, using a nucleic acid technique (NAT). This test is intended to be used to monitor the response of follicular lymphoma patients to cancer therapy with an EZH2 inhibitor (e.g., tazemetostat).

FDA categorySomatic gene mutation detection system

Device ID00875197005592

Catalog number07258321190

AvailabilityPrescription

MRI safetyLabeling does not contain MRI Safety Information

Contact

No contact is listed for this device.

Related products

Product	Model	Company	Device type
cobas® EGFR Mutation Test v2Roche Molecular Systems, Inc.Epidermal growth factor receptor (EGFR) gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)	2.0	Roche Molecular Systems, Inc.	Epidermal growth factor receptor (EGFR) gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)
RealTimeAbbott Molecular Inc.Isocitrate dehydrogenase 2 (IDH2) gene mutation IVD, kit, nucleic acid technique (NAT)	08N82-090	Abbott Molecular Inc.	Isocitrate dehydrogenase 2 (IDH2) gene mutation IVD, kit, nucleic acid technique (NAT)
therascreen® PDGFRA RGQ PCR KitQIAGEN GmbHGastrointestinal cancer genotyping IVD, kit, nucleic acid technique (NAT)	1	QIAGEN GmbH	Gastrointestinal cancer genotyping IVD, kit, nucleic acid technique (NAT)
PGDx elio™ serverPersonal Genome Diagnostics Inc.Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)	B-01-20800	Personal Genome Diagnostics Inc.	Cancer-related multiple gene mutation/mRNA expression IVD, kit, nucleic acid technique (NAT)

Product	Model	Company	Device type